New Risk • Aug 16
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. Cash payout ratio: 221% Dividend yield: 3.1% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (221% cash payout ratio). Share price has been volatile over the past 3 months (7.7% average weekly change). New Risk • Jul 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Buy Or Sell Opportunity • Jun 25
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 11% to €62.80. The fair value is estimated to be €81.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 8.7%. For the next 3 years, revenue is forecast to grow by 7.9% per annum. Earnings are also forecast to grow by 11% per annum over the same time period. Valuation Update With 7 Day Price Move • Jun 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €65.20, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €90.08 per share. Duyuru • Apr 04
Uzin Utz SE announces Annual dividend, payable on May 16, 2025 Uzin Utz SE announced Annual dividend of EUR 1.9000 per share payable on May 16, 2025, ex-date on May 14, 2025 and record date on May 15, 2025. Duyuru • Apr 03
Uzin Utz SE, Annual General Meeting, May 13, 2025 Uzin Utz SE, Annual General Meeting, May 13, 2025, at 10:30 W. Europe Standard Time. Reported Earnings • Aug 18
First half 2024 earnings released: EPS: €2.45 (vs €2.19 in 1H 2023) First half 2024 results: EPS: €2.45 (up from €2.19 in 1H 2023). Revenue: €242.3m (down 1.0% from 1H 2023). Net income: €12.4m (up 12% from 1H 2023). Profit margin: 5.1% (up from 4.5% in 1H 2023). Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 14% per year. Upcoming Dividend • May 16
Upcoming dividend of €1.60 per share Eligible shareholders must have bought the stock before 23 May 2024. Payment date: 27 May 2024. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (4.9%). Price Target Changed • Apr 04
Price target increased by 15% to €60.00 Up from €52.00, the current price target is provided by 1 analyst. New target price is 22% above last closing price of €49.00. Stock is down 7.5% over the past year. The company is forecast to post earnings per share of €4.30 for next year compared to €4.48 last year. Reported Earnings • Mar 30
Full year 2023 earnings released: EPS: €4.48 (vs €5.02 in FY 2022) Full year 2023 results: EPS: €4.48 (down from €5.02 in FY 2022). Revenue: €484.8m (flat on FY 2022). Net income: €22.6m (down 11% from FY 2022). Profit margin: 4.7% (down from 5.2% in FY 2022). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Duyuru • Mar 29
Uzin Utz SE, Annual General Meeting, May 22, 2024 Uzin Utz SE, Annual General Meeting, May 22, 2024. Location: Donauhalle, Ulm Ulm Germany New Risk • Mar 15
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 30
First half 2023 earnings released: EPS: €2.19 (vs €2.68 in 1H 2022) First half 2023 results: EPS: €2.19 (down from €2.68 in 1H 2022). Revenue: €244.7m (flat on 1H 2022). Net income: €11.0m (down 19% from 1H 2022). Profit margin: 4.5% (down from 5.5% in 1H 2022). Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 5% per year and the company’s share price has also fallen by 5% per year. Price Target Changed • Nov 16
Price target decreased to €68.00 Down from €95.00, the current price target is provided by 1 analyst. New target price is 41% above last closing price of €48.20. Stock is down 42% over the past year. The company posted earnings per share of €6.53 last year. Price Target Changed • Nov 07
Price target decreased to €68.00 Down from €95.00, the current price target is provided by 1 analyst. New target price is 56% above last closing price of €43.50. Stock is down 48% over the past year. The company posted earnings per share of €6.53 last year. Reported Earnings • Aug 29
First half 2022 earnings released: EPS: €0 (vs €3.98 in 1H 2021) First half 2022 results: EPS: €0 (down from €3.98 in 1H 2021). Revenue: €246.5m (up 11% from 1H 2021). Net income: €13.5m (down 33% from 1H 2021). Profit margin: 5.5% (down from 9.1% in 1H 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.7%, compared to a 2.4% growth forecast for the Chemicals industry in Germany. Buying Opportunity • Jun 11
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 19%. The fair value is estimated to be €75.07, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.3% over the last 3 years. Earnings per share has grown by 34%. Upcoming Dividend • May 11
Upcoming dividend of €1.80 per share Eligible shareholders must have bought the stock before 18 May 2022. Payment date: 20 May 2022. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (5.2%). Price Target Changed • Nov 18
Price target increased to €100.00 Up from €89.00, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €82.50. Stock is up 59% over the past year. The company posted earnings per share of €5.76 last year. Valuation Update With 7 Day Price Move • Sep 04
Investor sentiment improved over the past week After last week's 19% share price gain to €91.00, the stock trades at a trailing P/E ratio of 21.9x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 65% over the past three years. Reported Earnings • Aug 28
First half 2020 earnings released: EPS €2.01 (vs €2.14 in 1H 2019) The company reported a poor first half result with weaker earnings and profit margins, although revenues were flat. First half 2020 results: Revenue: €186.9m (flat on 1H 2019). Net income: €10.1m (down 5.9% from 1H 2019). Profit margin: 5.4% (down from 5.8% in 1H 2019). Price Target Changed • Aug 06
Price target increased to €95.00 Up from €85.00, the current price target is provided by 1 analyst. New target price is 28% above last closing price of €74.50. Stock is up 39% over the past year. Upcoming Dividend • May 20
Upcoming dividend of €1.55 per share Eligible shareholders must have bought the stock before 27 May 2021. Payment date: 31 May 2021. Trailing yield: 1.7%. Lower than top quartile of German dividend payers (3.3%). Lower than average of industry peers (3.6%). Price Target Changed • Feb 27
Price target raised to €85.00 Up from €78.00, the current price target is provided by 1 analyst. The new target price is 22% above the current share price of €69.40. As of last close, the stock is up 19% over the past year. Valuation Update With 7 Day Price Move • Feb 26
Investor sentiment improved over the past week After last week's 16% share price gain to €69.40, the stock is trading at a trailing P/E ratio of 16.4x, up from the previous P/E ratio of 14.2x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 16%. Is New 90 Day High Low • Feb 15
New 90-day high: €61.40 The company is up 20% from its price of €51.00 on 17 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. Price Target Changed • Feb 03
Price target raised to €78.00 Up from €70.50, the current price target is provided by 1 analyst. The new target price is 38% above the current share price of €56.40. As of last close, the stock is down 5.2% over the past year. Is New 90 Day High Low • Oct 24
New 90-day low: €51.00 The company is down 2.0% from its price of €52.00 on 24 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period. Is New 90 Day High Low • Sep 22
New 90-day high: €56.80 The company is up 4.0% from its price of €54.40 on 24 June 2020. The German market is also up 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period.